DE112007001600A5 - Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen - Google Patents

Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen Download PDF

Info

Publication number
DE112007001600A5
DE112007001600A5 DE112007001600T DE112007001600T DE112007001600A5 DE 112007001600 A5 DE112007001600 A5 DE 112007001600A5 DE 112007001600 T DE112007001600 T DE 112007001600T DE 112007001600 T DE112007001600 T DE 112007001600T DE 112007001600 A5 DE112007001600 A5 DE 112007001600A5
Authority
DE
Germany
Prior art keywords
contraception
risk
reduce
pharmaceutical composition
congenital malformations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE112007001600T
Other languages
English (en)
Inventor
Claus Dr. Claußen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jenapharm GmbH and Co KG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06016950A external-priority patent/EP1891959A1/de
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of DE112007001600A5 publication Critical patent/DE112007001600A5/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE112007001600T 2006-07-06 2007-05-05 Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen Withdrawn DE112007001600A5 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06014002.7 2006-07-06
EP06014002 2006-07-06
EP06016950.5 2006-08-14
EP06016950A EP1891959A1 (de) 2006-08-14 2006-08-14 Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
PCT/EP2007/003982 WO2008003363A1 (de) 2006-07-06 2007-05-05 Pharmazeutische zubereitung zur kontrazeption und zur verminderung des risikos angeborener fehlbildungen

Publications (1)

Publication Number Publication Date
DE112007001600A5 true DE112007001600A5 (de) 2009-04-30

Family

ID=38330771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE112007001600T Withdrawn DE112007001600A5 (de) 2006-07-06 2007-05-05 Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen

Country Status (16)

Country Link
US (1) US20080268048A1 (de)
EP (1) EP2037935A1 (de)
JP (1) JP2009542588A (de)
KR (1) KR20090029824A (de)
AR (1) AR061959A1 (de)
BR (1) BRPI0713999A2 (de)
CA (1) CA2665788A1 (de)
CL (1) CL2007001961A1 (de)
DE (1) DE112007001600A5 (de)
IL (1) IL196154A0 (de)
MX (1) MX2009000256A (de)
PE (1) PE20080400A1 (de)
RU (1) RU2009102443A (de)
TW (1) TW200810764A (de)
UY (1) UY30461A1 (de)
WO (1) WO2008003363A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
SI3310346T1 (sl) 2015-06-18 2021-07-30 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
CA2988498C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
RS62844B1 (sr) 2015-06-18 2022-02-28 Estetra Srl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CA2522761C (en) * 1998-04-17 2010-07-06 Michael E. Kafrissen Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
US7696219B2 (en) * 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
US20020147155A1 (en) * 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
NZ534806A (en) * 2002-02-21 2006-05-26 Schering Ag Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin B12
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
PL1755562T3 (pl) * 2004-05-28 2014-03-31 Richter Gedeon Nyrt Środek antykoncepcyjny zawierający kwas foliowy
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.

Also Published As

Publication number Publication date
RU2009102443A (ru) 2010-08-20
KR20090029824A (ko) 2009-03-23
BRPI0713999A2 (pt) 2012-11-20
TW200810764A (en) 2008-03-01
UY30461A1 (es) 2008-02-29
MX2009000256A (es) 2009-02-18
US20080268048A1 (en) 2008-10-30
WO2008003363A1 (de) 2008-01-10
PE20080400A1 (es) 2008-07-04
AR061959A1 (es) 2008-08-10
IL196154A0 (en) 2009-09-22
EP2037935A1 (de) 2009-03-25
JP2009542588A (ja) 2009-12-03
CA2665788A1 (en) 2008-01-10
CL2007001961A1 (es) 2008-01-11

Similar Documents

Publication Publication Date Title
DE112007001600A5 (de) Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
CR10406A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
IL192773A0 (en) Microparticulate pharmaceutical forms resistant to immediate release of the active ingredient in the presence of alcohol
HK1156038A1 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
ZA200900347B (en) Preparation of pharmaceutical compositions
IL195491A (en) Pharmaceutical preparations containing tmc278 and processes for their preparation
IL199853A (en) Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
HRP20181854T1 (hr) Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica
ZA200801592B (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
IL184558A0 (en) Sustained release composition of protein drug
ZA200810178B (en) Pharmaceutical compositions for sustained release of phenyephrine
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
HRP20130791T1 (en) Pharmaceutical compositions for the treatment of capillary arteriopathy
EP2007371A4 (de) Lactat und calciumhaltige pharmazeutische zusammensetzung und ihre verwendungen
GB0815632D0 (en) Compositions and methods for promoting the healing of tissue of multicellular organisms
GB0623897D0 (en) Pharmaceutical composition of memantine
SI2258361T1 (sl) Raba derivata benzofenona ali soli le-tega v kombinaciji z inhibitorjem tnfalfa ter farmacevtska sestava, vsebujoäśa derivat ali sol le-tega in inhibitor
GB0619891D0 (en) Pharmaceutical composition of risedronate
PL383272A1 (pl) Kompozycja farmaceutyczna przydatna w leczeniu chorób wirusowych
PL383271A1 (pl) Kompozycja farmaceutyczna przydatna w leczeniu chorób wirusowych
IL198994A0 (en) Use of incensole and incensole acetate for the preparation of pharmaceutical compositions
GB0724523D0 (en) Pharmaceutical compositions comprising clotrimazole or analogs thereof and their use

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: JENAPHARM GMBH & CO. KG, 07745 JENA, DE

R120 Application withdrawn or ip right abandoned

Effective date: 20110730